InvestorsHub Logo
Followers 3156
Posts 961293
Boards Moderated 204
Alias Born 09/04/2000

Re: None

Tuesday, 11/01/2016 1:36:25 AM

Tuesday, November 01, 2016 1:36:25 AM

Post# of 894
MACK News: Merrimack Announces Acceptance for Review of ANDA filed by Actavis for Generic Doxorubicin Hydrochloride Liposome Injection (... 10/31/2016 07:30:00 AM
MACK News: Shire Granted EU Marketing Authorization of Onivyde®, in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the ... 10/18/2016 02:00:00 AM
MACK News: Shire Granted EU Marketing Authorization of Onivyde®, in Combination With 5-Fluorouracil (5-FU) and Leucovorin (LV),for the ... 10/18/2016 02:00:00 AM
MACK News: Current Report Filing (8-k) 10/14/2016 04:32:34 PM
MACK News: Final Results of NAPOLI-1 Study Confirm Overall Survival and Progression-Free Survival Benefit for the ONIVYDE® Regimen for ... 10/11/2016 07:30:00 AM
News News Alert: Merrimack Announces Acceptance for Review of ANDA filed by Actavis for Generic Doxorubicin Hydrochloride Liposome Injection (... 10/31/2016 07:30:00 AM
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MACK News